Clinical Trial Update: IncobotulinumtoxinA for Provoked Vestibulodynia With Overactive Pelvic Floor Muscle Dysfunction [Phase 2]

View source ↗

Summary

Phase 2 study evaluating incobotulinumtoxinA for provoked vestibulodynia with overactive pelvic floor muscle dysfunction is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Provoked Vestibulodynia

Drugs mentioned

• IncobotulinumtoxinA (incobotulinumtoxinA)

Snippet

Sponsor: Center for Vulvovaginal Disorders | Conditions: Provoked Vestibulodynia | Phase 2 | Status: RECRUITING